Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001086364-12-002798
Filing Date
2012-08-09
Accepted
2012-08-08 20:28:45
Documents
1

Document Format Files

Seq Description Document Type Size
1 synta.pharmaceuticals.corp..txt SC 13G/A 11147
  Complete submission text file 0001086364-12-002798.txt   12691
Mailing Address
Business Address 45 HARTWELL AVE LEXINGTON MA 02421 781-274-8200
SYNTA PHARMACEUTICALS CORP (Subject) CIK: 0001157601 (see all company filings)

EIN.: 000000000
Type: SC 13G/A | Act: 34 | File No.: 005-82674 | Film No.: 121018249
SIC: 2834 Pharmaceutical Preparations

Mailing Address 55 EAST 52ND STREET NEW YORK NY 10055
Business Address 55 EAST 52ND STREET NEW YORK NY 10055 212-810-5300
BlackRock Inc. (Filed by) CIK: 0001364742 (see all company filings)

EIN.: 320174431 | State of Incorp.: DE | Fiscal Year End: 0226
Type: SC 13G/A
SIC: 6211 Security Brokers, Dealers & Flotation Companies